Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients (LIVERAL)

This study has been completed.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) Identifier:
First received: November 26, 2009
Last updated: July 17, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)